These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34251133)

  • 1. Type 1 Brugada-Electrocardiogram: A Rare Presentation in a 57-Year-Old Woman with Paroxysmal Atrial Fibrillation Treated with a Therapeutic Dose of Propafenone.
    Mowaswes M; Biton Y; Belhassen B
    Isr Med Assoc J; 2021 Jul; 23(7):456-458. PubMed ID: 34251133
    [No Abstract]   [Full Text] [Related]  

  • 2. Likelihood of Brugada ECG pattern confirmed after propafenone administration for atrial fibrillation cardioversion.
    Dragios TD; Manolis AG; Kyriakides ZS
    Acta Cardiol; 2011 Jun; 66(3):399-400. PubMed ID: 21744716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation.
    Daubert JP
    Cardiol J; 2009; 16(6):491-2. PubMed ID: 19950083
    [No Abstract]   [Full Text] [Related]  

  • 4. [A comparison between propafenone and hydroquinidine perorally in the treatment of recent-onset atrial fibrillation].
    Satullo G; Arrigo F; Cavallaro L; Coglitore A; Fazio F; Saporito F; Sorrenti S; Oreto G
    Minerva Cardioangiol; 1996 Mar; 44(3):141-4. PubMed ID: 8767614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concealed Brugada syndrome that became apparent incidentally during atrial fibrillation therapy].
    Yiğiner O; Kılıçaslan F; Tokatlı A; Işılak Z
    Turk Kardiyol Dern Ars; 2011 Mar; 39(2):159-62. PubMed ID: 21430424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined administration of quinidine and propafenone for atrial fibrillation: the CAQ-PAF study.
    O'Hara GE; Philippon F; Gilbert M; Champagne J; Michaud V; Charbonneau L; Pruneau G; Hamelin BA; Geelen P; Turgeon J
    J Clin Pharmacol; 2012 Feb; 52(2):171-9. PubMed ID: 21508180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
    Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shock Reduction With Long-Term Quinidine in Patients With Brugada Syndrome and Malignant Ventricular Arrhythmia Episodes.
    Anguera I; García-Alberola A; Dallaglio P; Toquero J; Pérez L; Martínez JG; Peinado R; Rubín JM; Brugada J; Cequier A
    J Am Coll Cardiol; 2016 Apr; 67(13):1653-1654. PubMed ID: 27150692
    [No Abstract]   [Full Text] [Related]  

  • 9. Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine.
    Lau CP; Chow MS; Tse HF; Tang MO; Fan C
    Am J Cardiol; 2000 Dec; 86(12):1327-32. PubMed ID: 11113407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation, pharmacological cardioversion and topical ophthalmic beta-blocker use.
    Patane' S; Marte F; Di Bella G; Pugliatti P
    Int J Cardiol; 2008 Jun; 126(3):e43-6. PubMed ID: 17418438
    [No Abstract]   [Full Text] [Related]  

  • 11. Propafenone-induced Brugada-like ECG changes mistaken as acute myocardial infarction.
    Chutani S; Imran N; Grubb B; Kanjwal Y
    Emerg Med J; 2008 Feb; 25(2):117-8. PubMed ID: 18212157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
    Lee SH; Chen SA; Chiang CE; Tai CT; Wen ZC; Wang SP; Chang MS
    J Intern Med; 1996 Mar; 239(3):253-60. PubMed ID: 8772625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Termination of paroxysm of atrial fibrillation conversion using oral propafenone after unsuccessful electrical cardioversion].
    Kupriianova OG; Pavlov AV; Vaniev SB; Doshchitsin VL
    Kardiologiia; 2012; 52(4):95-6. PubMed ID: 22839523
    [No Abstract]   [Full Text] [Related]  

  • 14. Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation.
    Antonielli E; Pizzuti A; Bassignana A; Tanga M; Baralis G; Rovere ME; Di Leo M
    Am J Cardiol; 1999 Nov; 84(9):1092-6, A9-10. PubMed ID: 10569673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrial fibrillation].
    Cárdenas M
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-9-S2-13. PubMed ID: 17969499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brugada-type ECG pattern in patients treated with oral flecainide for lone atrial fibrillation: is there any clinical implication?
    Letsas KP; Weber R; Arentz T; Kalusche D
    Hellenic J Cardiol; 2009; 50(4):338-9. PubMed ID: 19622506
    [No Abstract]   [Full Text] [Related]  

  • 17. [Propafenone versus hydroquinidine in long-term pharmacological prophylaxis of atrial fibrillation].
    Richiardi E; Gaita F; Greco C; Gaschino G; Comba Costa G; Rosettani E; Brusca A
    Cardiologia; 1992 Feb; 37(2):123-7. PubMed ID: 1600529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.
    Bianconi L; Mennuni M; Lukic V; Castro A; Chieffi M; Santini M
    J Am Coll Cardiol; 1996 Sep; 28(3):700-6. PubMed ID: 8772759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful conversion of recent-onset atrial fibrillation by sequential administration of up to three antiarrhythmic drugs.
    Milicevic G; Gavranovic Z; Bakula M; Pazur V; Frank B
    Clin Cardiol; 2008 Oct; 31(10):472-7. PubMed ID: 18855351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
    Fresco C; Proclemer A; Pavan A; Buia G; Vicentini A; Pavan D; Morgera T
    Clin Cardiol; 1996 May; 19(5):409-12. PubMed ID: 8723601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.